![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 10, 8035-8042, March 7, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
**
§§
From the Departments of Sialic acid is a major determinant of
carbohydrate-receptor interactions in many systems pertinent to human
health and disease. N-Acetylmannosamine (ManNAc) is the
first committed intermediate in the sialic acid biosynthetic pathway;
thus, the mechanisms that control intracellular ManNAc levels are
important regulators of sialic acid production. UDP-GlcNAc 2-epimerase
and GlcNAc 2-epimerase are two enzymes capable of generating ManNAc
from UDP-GlcNAc and GlcNAc, respectively. Whereas the former enzyme has
been shown to direct metabolic flux toward sialic acid in
vivo, the function of the latter enzyme is unclear. Here we study
the effects of GlcNAc 2-epimerase expression on sialic acid production
in cells. A key tool we developed for this study is a cell-permeable,
small molecule inhibitor of GlcNAc 2-epimerase designed based on
mechanistic principles. Our results indicate that, unlike UDP-GlcNAc
2-epimerase, which promotes biosynthesis of sialic acid, GlcNAc
2-epimerase can serve a catabolic role, diverting metabolic flux away
from the sialic acid pathway.
Chemistry and
Molecular and Cell Biology and the ** Howard Hughes
Medical Institute, University of California, Berkeley, California 94720 and the 
Center for Advanced Materials,
Materials Science Division, Lawrence Berkeley National Laboratory,
Berkeley, California 94720, and the ¶ Department of
Bioengineering, Akita Research Institute of Food and Brewing, 4-26 Sanuki, Arayamachi, Akita 010-1623, Japan
This article has been cited by other articles:
![]() |
P. Maliekal, D. Vertommen, G. Delpierre, and E. Van Schaftingen Identification of the sequence encoding N-acetylneuraminate-9-phosphate phosphatase Glycobiology, February 1, 2006; 16(2): 165 - 172. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Sparks, C. Ciccone, M. Lalor, E. Orvisky, R. Klootwijk, P. J. Savelkoul, M. C. Dalakas, D. M. Krasnewich, W. A. Gahl, and M. Huizing Use of a cell-free system to determine UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities in human hereditary inclusion body myopathy Glycobiology, November 1, 2005; 15(11): 1102 - 1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hong and P. Stanley Lec3 Chinese Hamster Ovary Mutants Lack UDP-N-acetylglucosamine 2-Epimerase Activity Because of Mutations in the Epimerase Domain of the Gne Gene J. Biol. Chem., December 26, 2003; 278(52): 53045 - 53054. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |